Mapping	O
of	O
the	O
transcriptional	B-protein
repression	I-protein
domain	I-protein
of	O
the	O
lymphoid-specific	B-protein
transcription	I-protein
factor	I-protein
oct-2A	B-protein
.	O

The	O
lymphoid-specific	B-protein
transcription	I-protein
factor	I-protein
Oct-2a	B-protein
is	O
implicated	O
in	O
B	O
cell-specific	O
transcriptional	O
activity	O
via	O
the	O
octamer	O
motif	O
.	O

Structure/function	O
analysis	O
of	O
various	O
Oct-2a	B-protein
effector	I-protein
regions	I-protein
in	O
the	O
context	O
of	O
the	O
GAL4	B-protein
DNA-binding	I-protein
domain	I-protein
revealed	O
that	O
Oct-2a	B-protein
contains	O
two	O
functionally	O
different	O
activation	B-protein
domains	I-protein
at	O
the	O
N	B-protein
and	I-protein
the	I-protein
C	I-protein
termini	I-protein
.	O

The	O
transcriptional	O
activity	O
of	O
both	O
domains	O
is	O
strongly	O
potentiated	O
by	O
interactions	O
with	O
distinct	O
B	B-protein
cell-specific	I-protein
coactivators	I-protein
.	O

Recently	O
,	O
we	O
have	O
identified	O
a	O
repression	B-protein
domain	I-protein
located	O
within	O
the	O
N	B-protein
terminus	I-protein
of	O
Oct-2a	B-protein
(	O
amino	B-protein
acids	I-protein
2-99	I-protein
)	O
.	O

When	O
this	O
domain	O
was	O
transferred	O
to	O
a	O
potent	O
activator	O
,	O
transcription	O
was	O
strongly	O
inhibited	O
.	O

In	O
this	O
study	O
we	O
present	O
a	O
deletion	O
analysis	O
of	O
the	O
N-terminal	B-protein
region	I-protein
of	O
Oct-2a	B-protein
to	O
determine	O
the	O
minimal	B-protein
repression	I-protein
domain	I-protein
.	O

We	O
identified	O
a	O
stretch	O
of	O
23	O
amino	O
acids	O
,	O
rich	O
in	O
serine	O
and	O
threonine	O
residues	O
,	O
which	O
was	O
responsible	O
for	O
most	O
of	O
the	O
repression	O
activity	O
.	O

We	O
show	O
that	O
repression	O
is	O
strongly	O
dependent	O
on	O
the	O
type	O
of	O
enhancer	B-DNA
present	O
in	O
the	O
reporter	B-DNA
plasmid	I-DNA
as	O
well	O
as	O
on	O
the	O
cell	B-cell_line
line	I-cell_line
tested	O
.	O

The	O
possibility	O
that	O
Oct-2a	B-protein
can	O
act	O
as	O
an	O
activator	O
and/or	O
a	O
repressor	O
may	O
have	O
important	O
consequences	O
for	O
the	O
function	O
of	O
Oct-2a	B-protein
in	O
B	O
cell	O
differentiation	O
and	O
other	O
developmental	O
processes	O
.	O

Communication	NULL
Mapping	NULL
of	NULL
the	NULL
Transcriptional	NULL
Repression	NULL
Domain	NULL
of	NULL
the	NULL
Lymphoid-specific	NULL
Transcription	NULL
Factor	NULL
Oct-2A*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
March	NULL
22	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
April	NULL
23	NULL
,	NULL
1996	NULL
)	NULL
Erika	NULL
M.	NULL
Friedl	NULL
and	NULL
Patrick	NULL
Matthias	NULL
?	NULL

From	NULL
the	NULL
Friedrich	NULL
Miescher-Institut	NULL
,	NULL
P.	NULL
O	NULL
.	NULL

Box	NULL
2543	NULL
,	NULL
CH-4002	NULL
Basel	NULL
,	NULL
Switzerland	NULL
The	NULL
lymphoid-specific	NULL
transcription	NULL
factor	NULL
Oct-2a	NULL
is	NULL
implicated	NULL
in	NULL
B	NULL
cell-specific	NULL
transcriptional	NULL
activity	NULL
via	NULL
the	NULL
octamer	NULL
motif	NULL
.	NULL

Structure/function	NULL
analysis	NULL
of	NULL
various	NULL
Oct-2a	NULL
effector	NULL
regions	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
GAL4	NULL
DNA-binding	NULL
domain	NULL
revealed	NULL
that	NULL
Oct-2a	NULL
contains	NULL
two	NULL
functionally	NULL
different	NULL
activation	NULL
domains	NULL
at	NULL
the	NULL
N	NULL
and	NULL
the	NULL
C	NULL
termini	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
both	NULL
domains	NULL
is	NULL
strongly	NULL
potentiated	NULL
by	NULL
interactions	NULL
with	NULL
distinct	NULL
B	NULL
cell-specific	NULL
coactivators	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
repression	NULL
domain	NULL
located	NULL
within	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
Oct-2a	NULL
(	NULL
amino	NULL
acids	NULL
2-99	NULL
)	NULL
.	NULL

When	NULL
this	NULL
domain	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
potent	NULL
activator	NULL
,	NULL
transcription	NULL
was	NULL
strongly	NULL
inhibited	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
present	NULL
a	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
Oct-2a	NULL
to	NULL
determine	NULL
the	NULL
minimal	NULL
repression	NULL
domain	NULL
.	NULL

We	NULL
identified	NULL
a	NULL
stretch	NULL
of	NULL
23	NULL
amino	NULL
acids	NULL
,	NULL
rich	NULL
in	NULL
serine	NULL
and	NULL
threonine	NULL
residues	NULL
,	NULL
which	NULL
was	NULL
responsible	NULL
for	NULL
most	NULL
of	NULL
the	NULL
repression	NULL
activity	NULL
.	NULL

We	NULL
show	NULL
that	NULL
repression	NULL
is	NULL
strongly	NULL
dependent	NULL
on	NULL
the	NULL
type	NULL
of	NULL
enhancer	NULL
present	NULL
in	NULL
the	NULL
reporter	NULL
plasmid	NULL
as	NULL
well	NULL
as	NULL
on	NULL
the	NULL
cell	NULL
line	NULL
tested	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
Oct-2a	NULL
can	NULL
act	NULL
as	NULL
an	NULL
activator	NULL
and/or	NULL
a	NULL
repressor	NULL
may	NULL
have	NULL
important	NULL
consequences	NULL
for	NULL
the	NULL
function	NULL
of	NULL
Oct-2a	NULL
in	NULL
B	NULL
cell	NULL
differentiation	NULL
and	NULL
other	NULL
developmental	NULL
processes	NULL
.	NULL

The	NULL
B	NULL
cell-restricted	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
genes	NULL
is	NULL
dependent	NULL
on	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
that	NULL
confer	NULL
B	NULL
cell-specificity	NULL
.	NULL

The	NULL
octamer	NULL
motif	NULL
ATGCAAAT	NULL
or	NULL
its	NULL
inverse	NULL
complement	NULL
is	NULL
a	NULL
pivotal	NULL
regulatory	NULL
element	NULL
for	NULL
transcription	NULL
of	NULL
all	NULL
Ig	NULL
genes	NULL
.	NULL

It	NULL
is	NULL
conserved	NULL
in	NULL
all	NULL
Ig	NULL
promoters	NULL
and	NULL
most	NULL
of	NULL
the	NULL
Ig	NULL
enhancers	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
variety	NULL
of	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
2	NULL
)	NULL
,	NULL
including	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
Oct-1	NULL
protein	NULL
(	NULL
3	NULL
)	NULL
and	NULL
the	NULL
lymphoid-specific	NULL
factor	NULL
Oct-2	NULL
(	NULL
4	NULL
)	NULL
.	NULL

These	NULL
octamer	NULL
site-binding	NULL
factors	NULL
are	NULL
implicated	NULL
in	NULL
developmentally	NULL
regulated	NULL
gene	NULL
expression	NULL
(	NULL
2	NULL
,	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
Oct-2	NULL
gene	NULL
in	NULL
mice	NULL
has	NULL
shown	NULL
that	NULL
Oct-2	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
final	NULL
stage	NULL
of	NULL
B	NULL
cell	NULL
differentiation	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
more	NULL
recently	NULL
a	NULL
new	NULL
role	NULL
for	NULL
Oct-2	NULL
,	NULL
as	NULL
a	NULL
nuclear	NULL
mediator	NULL
of	NULL
B	NULL
cell	NULL
proliferation	NULL
,	NULL
has	NULL
been	NULL
suggested	NULL
(	NULL
8	NULL
)	NULL
.	NULL

*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
}	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
41-61-6976661	NULL
;	NULL
Fax	NULL
:	NULL
41-61-6973976	NULL
;	NULL
E-mail	NULL
:	NULL
matthias	NULL
@	NULL
fmi.ch	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
Ig	NULL
,	NULL
immunoglobulin	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
FCS	NULL
,	NULL
fetal	NULL
calf	NULL
serum	NULL
;	NULL
SV40	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
;	NULL
aa	NULL
,	NULL
amino	NULL
acid	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Tux	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

24	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
14	NULL
,	NULL
pp	NULL
.	NULL

13927-13930	NULL
,	NULL
1996	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc	NULL
.	NULL

Printed	NULL
in	NULL
U.S.A.	NULL
By	NULL
transient	NULL
transfections	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
reac-tions	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
,	NULL
together	NULL
with	NULL
the	NULL
B	NULL
cell	NULL
coactivator	NULL
Bobl/OBF-1/0CA-B	NULL
,	NULL
efficiently	NULL
stimulate	NULL
Ig	NULL
promoter	NULL
activity	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

This	NULL
B	NULL
cell	NULL
coactivator	NULL
interacts	NULL
with	NULL
the	NULL
DNA-binding	NULL
POU	NULL
domains	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
to	NULL
potentiate	NULL
transcription	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
presented	NULL
evidence	NULL
for	NULL
additional	NULL
distinct	NULL
B	NULL
cell-specific	NULL
activities	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
functionally	NULL
different	NULL
activation	NULL
domains	NULL
of	NULL
Oct-2a	NULL
to	NULL
enhance	NULL
transcriptional	NULL
stimulation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
study	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
repression	NULL
domain	NULL
within	NULL
the	NULL
N-terminal	NULL
99	NULL
residues	NULL
of	NULL
Oct-2a	NULL
.	NULL

Recently	NULL
,	NULL
different	NULL
negative	NULL
regulatory	NULL
regions	NULL
have	NULL
been	NULL
defined	NULL
within	NULL
other	NULL
isoforms	NULL
of	NULL
Oct-2	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

For	NULL
a	NULL
long	NULL
time	NULL
research	NULL
has	NULL
focused	NULL
mainly	NULL
on	NULL
activator	NULL
and	NULL
coactivator	NULL
proteins	NULL
(	NULL
15-17	NULL
)	NULL
,	NULL
but	NULL
recently	NULL
it	NULL
became	NULL
clear	NULL
that	NULL
repressors	NULL
and	NULL
corepressors	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

Repressors	NULL
can	NULL
act	NULL
by	NULL
passive	NULL
repression	NULL
strategies	NULL
such	NULL
as	NULL
competition	NULL
for	NULL
DNA-binding	NULL
sites	NULL
,	NULL
quenching	NULL
,	NULL
squelching	NULL
,	NULL
or	NULL
the	NULL
establishment	NULL
of	NULL
a	NULL
repressive	NULL
chromatin	NULL
structure	NULL
around	NULL
the	NULL
target	NULL
promoter	NULL
.	NULL

Active	NULL
repression	NULL
mechanisms	NULL
are	NULL
also	NULL
involved	NULL
and	NULL
imply	NULL
a	NULL
direct	NULL
or	NULL
indirect	NULL
(	NULL
using	NULL
a	NULL
corepressor	NULL
)	NULL
interaction	NULL
with	NULL
the	NULL
transcription	NULL
machinery	NULL
,	NULL
thus	NULL
interfering	NULL
with	NULL
preinitiation	NULL
complex	NULL
assembly	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
several	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
investigated	NULL
function	NULL
as	NULL
both	NULL
activators	NULL
and	NULL
repressors	NULL
depending	NULL
on	NULL
the	NULL
target	NULL
promoter	NULL
and	NULL
the	NULL
cellular	NULL
context	NULL
(	NULL
21	NULL
)	NULL
.	NULL

This	NULL
could	NULL
also	NULL
be	NULL
the	NULL
case	NULL
for	NULL
Oct-2a	NULL
,	NULL
which	NULL
belongs	NULL
to	NULL
a	NULL
group	NULL
of	NULL
transcription	NULL
factors	NULL
with	NULL
a	NULL
complex	NULL
modular	NULL
structure	NULL
consisting	NULL
of	NULL
separable	NULL
domains	NULL
for	NULL
activation	NULL
and	NULL
repression	NULL
(	NULL
12	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
Kriippel	NULL
(	NULL
22	NULL
)	NULL
,	NULL
Even-skipped	NULL
(	NULL
22	NULL
)	NULL
,	NULL
Egr-1	NULL
(	NULL
23	NULL
)	NULL
,	NULL
and	NULL
YY1	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
describe	NULL
a	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
N-terminal	NULL
domain	NULL
of	NULL
Oct-2a	NULL
(	NULL
N1	NULL
region	NULL
)	NULL
in	NULL
order	NULL
to	NULL
define	NULL
the	NULL
region	NULL
involved	NULL
in	NULL
transcriptional	NULL
repression	NULL
.	NULL

Different	NULL
segments	NULL
of	NULL
the	NULL
N1	NULL
region	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
potent	NULL
activator	NULL
protein	NULL
GAL4-C-C	NULL
and	NULL
tested	NULL
in	NULL
transient	NULL
transfections	NULL
of	NULL
B	NULL
cells	NULL
and	NULL
non-lymphoid	NULL
cells	NULL
together	NULL
with	NULL
luciferase-based	NULL
reporter	NULL
plasmids	NULL
containing	NULL
different	NULL
enhancers	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
major	NULL
repressor	NULL
activity	NULL
mapped	NULL
to	NULL
a	NULL
region	NULL
of	NULL
23	NULL
amino	NULL
acids	NULL
with	NULL
a	NULL
high	NULL
abundance	NULL
of	NULL
serine	NULL
and	NULL
threonine	NULL
residues	NULL
(	NULL
30.4	NULL
%	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
transcriptional	NULL
repression	NULL
displayed	NULL
cell	NULL
type-specific	NULL
characteristics	NULL
,	NULL
which	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
enhancer	NULL
present	NULL
in	NULL
the	NULL
reporter	NULL
plasmid	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Construction	NULL
of	NULL
Plasmids-The	NULL
expression	NULL
vectors	NULL
pGAL4	NULL
,	NULL
pGAL4-C-C	NULL
,	NULL
pN1-GAL4-C-C	NULL
,	NULL
and	NULL
pN2-GAL4-C-C	NULL
were	NULL
constructed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

pGAL4	NULL
encodes	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
GALA4	NULL
(	NULL
residues	NULL
1-147	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
pGAL4-C-C	NULL
encodes	NULL
a	NULL
fusion	NULL
protein	NULL
containing	NULL
GAL4	NULL
(	NULL
residues	NULL
1-147	NULL
)	NULL
linked	NULL
to	NULL
a	NULL
duplicated	NULL
Oct-2a	NULL
C	NULL
terminus	NULL
(	NULL
residues	NULL
463-479	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vectors	NULL
pNI-GAL4-C-C	NULL
and	NULL
pN2-GAL4-C-C	NULL
were	NULL
made	NULL
by	NULL
linking	NULL
the	NULL
N-terminal	NULL
fragments	NULL
N1	NULL
,	NULL
encoding	NULL
amino	NULL
acids	NULL
2-99	NULL
,	NULL
and	NULL
N2	NULL
,	NULL
encoding	NULL
residues	NULL
163-207	NULL
,	NULL
of	NULL
Oct-2a	NULL
to	NULL
pGAL4-C-C	NULL
.	NULL

The	NULL
chimeric	NULL
constructs	NULL
pN3-GAL4-C-C	NULL
,	NULL
pN4-GAL4-C-C	NULL
,	NULL
and	NULL
pN5-GAL4-C-C	NULL
were	NULL
generated	NULL
by	NULL
introduction	NULL
of	NULL
the	NULL
Asp718-BamHI-cleaved	NULL
polymerase	NULL
chain	NULL
reaction	NULL
fragments	NULL
N3	NULL
,	NULL
N4	NULL
,	NULL
and	NULL
N5	NULL
into	NULL
the	NULL
respective	NULL
sites	NULL
of	NULL
pGAL4-C-C	NULL
.	NULL

The	NULL
N3	NULL
fragment	NULL
encodes	NULL
the	NULL
amino	NULL
acids	NULL
2-64	NULL
of	NULL
Oct-2a	NULL
and	NULL
was	NULL
amplified	NULL
with	NULL
the	NULL
primers	NULL
5'-TACTC-AGGATCCGTTCACTCCAGCATGGG-3	NULL
'	NULL
and	NULL
5-GTCCTTGGTACCCT-TGATCTTTGTACTG-3	NULL
'	NULL
.	NULL

The	NULL
N4	NULL
region	NULL
,	NULL
encoding	NULL
residues	NULL
42-99	NULL
of	NULL
Oct-2a	NULL
,	NULL
was	NULL
generated	NULL
with	NULL
the	NULL
oligonucleotide	NULL
primers	NULL
5'-TAGAG-GATCCCATCAGAACCCCCAA-3	NULL
'	NULL
and	NULL
5-CATCTTGGTACCTAGCTG-GCTGCCCGTC-3	NULL
'	NULL
.	NULL

The	NULL
N5	NULL
fragment	NULL
,	NULL
encoding	NULL
Oct-2a	NULL
residues	NULL
65-99	NULL
,	NULL
13927	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
13928	NULL
POU	NULL
domain	NULL
F	NULL
--	NULL
-	NULL
--	NULL
I	NULL
SPECIFIC	NULL
-	NULL
HOMEO	NULL
oct2A	NULL
1	NULL
E	NULL
pa	NULL
mm	NULL
``	NULL
49	NULL
a	NULL
PSMIP	NULL
activation	NULL
domain	NULL
II	NULL
activation	NULL
domain	NULL
1	NULL
GAL4	NULL
aes	NULL
GAL4-C-C	NULL
Nt-GaL4cc	NULL
N2-GAL4-C-C	NULL
ne-car4cC	NULL
N4-GAL4C-C	NULL
NS-GAL4-C-C	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Oct-2a	NULL
and	NULL
the	NULL
GAL4-Oct-2a	NULL
fusion	NULL
proteins	NULL
.	NULL

A	NULL
,	NULL
structure	NULL
of	NULL
Oct-2a	NULL
with	NULL
the	NULL
activation	NULL
domains	NULL
I	NULL
and	NULL
II	NULL
as	NULL
well	NULL
as	NULL
the	NULL
potential	NULL
repressing	NULL
domains	NULL
N1	NULL
,	NULL
N2	NULL
,	NULL
N3	NULL
,	NULL
N4	NULL
,	NULL
and	NULL
N5	NULL
within	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
Oct-2a	NULL
.	NULL

B	NULL
,	NULL
schematic	NULL
outline	NULL
of	NULL
the	NULL
GAL4-Oct-2a	NULL
chimeric	NULL
proteins	NULL
tested	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

The	NULL
proteins	NULL
contain	NULL
different	NULL
effector	NULL
regions	NULL
linked	NULL
to	NULL
the	NULL
GAL4	NULL
DNA-binding	NULL
domain	NULL
(	NULL
aa	NULL
1-147	NULL
)	NULL
.	NULL

GAL4-C-C	NULL
contains	NULL
the	NULL
duplicated	NULL
C	NULL
terminus	NULL
of	NULL
Oct-2a	NULL
(	NULL
aa	NULL
363-479	NULL
)	NULL
.	NULL

The	NULL
regions	NULL
N1	NULL
(	NULL
aa	NULL
2-99	NULL
)	NULL
,	NULL
N2	NULL
(	NULL
aa	NULL
163-207	NULL
)	NULL
,	NULL
N3	NULL
(	NULL
aa	NULL
2-64	NULL
)	NULL
,	NULL
N4	NULL
(	NULL
aa	NULL
42-99	NULL
)	NULL
,	NULL
and	NULL
N5	NULL
(	NULL
aa	NULL
65-99	NULL
)	NULL
of	NULL
Oct-2a	NULL
are	NULL
fused	NULL
to	NULL
the	NULL
potent	NULL
activator	NULL
protein	NULL
GAL4-C-C	NULL
to	NULL
test	NULL
their	NULL
repression	NULL
activity	NULL
.	NULL

In	NULL
A	NULL
and	NULL
B	NULL
,	NULL
the	NULL
structural	NULL
representation	NULL
of	NULL
the	NULL
domains	NULL
is	NULL
drawn	NULL
to	NULL
scale	NULL
.	NULL

was	NULL
amplified	NULL
using	NULL
the	NULL
oligonucleotide	NULL
primers	NULL
5'-GGTAGGATCCG-CTGAAGACCCCAGTG-3	NULL
'	NULL
and	NULL
5'-CATCTTGGTACCTAGCTGGCTGC-CCGTC-3	NULL
'	NULL
.	NULL

The	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
restriction	NULL
analysis	NULL
and	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
p2GucE	NULL
and	NULL
p2GlucBG5	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
target	NULL
vector	NULL
p2GlucE	NULL
contains	NULL
two	NULL
Gal4-binding	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
13	NULL
base	NULL
pairs	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
minimal	NULL
rabbit	NULL
-globin	NULL
promoter	NULL
and	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
enhancer	NULL
2.85	NULL
kilobase	NULL
pairs	NULL
downstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
p2GlucBGS	NULL
has	NULL
the	NULL
same	NULL
structure	NULL
as	NULL
p2GlucE	NULL
but	NULL
contains	NULL
,	NULL
instead	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
,	NULL
a	NULL
synthetic	NULL
enhancer	NULL
consisting	NULL
of	NULL
five	NULL
Gal4-binding	NULL
sites	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transient	NULL
Transfections-Namalwa	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
and	NULL
50	NULL
uM	NULL
B-mercaptoethanol	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
3	NULL
%	NULL
FCS	NULL
and	NULL
3	NULL
%	NULL
newborn	NULL
calf	NULL
serum	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

For	NULL
the	NULL
transient	NULL
activation	NULL
assays	NULL
,	NULL
HeLa	NULL
and	NULL
Namalwa	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
6	NULL
pg	NULL
of	NULL
reporter	NULL
and	NULL
4	NULL
ug	NULL
of	NULL
effector	NULL
plasmids	NULL
.	NULL

For	NULL
protein	NULL
expression	NULL
,	NULL
COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
.	NULL

Transfections	NULL
contained	NULL
a	NULL
total	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
DNA	NULL
for	NULL
HeLa	NULL
cells	NULL
or	NULL
10	NULL
ug	NULL
for	NULL
Namalwa	NULL
cells	NULL
and	NULL
5	NULL
ug	NULL
for	NULL
COS-7	NULL
cells	NULL
.	NULL

Sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
Pharmacia	NULL
)	NULL
was	NULL
used	NULL
as	NULL
carrier	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
coprecipitation	NULL
method	NULL
for	NULL
HeLa	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
and	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
procedure	NULL
(	NULL
26	NULL
)	NULL
for	NULL
Namalwa	NULL
and	NULL
COS-7	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Repression	NULL
by	NULL
Oct-2A	NULL
£09	NULL
wﬁiﬁh	NULL
y	NULL
a	NULL
h	NULL
}	NULL
l	NULL
”	NULL
Bulk	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

EMSA	NULL
with	NULL
transiently	NULL
expressed	NULL
GAL4-Oct-2a	NULL
fusion	NULL
proteins	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
3	NULL
pg	NULL
of	NULL
the	NULL
various	NULL
expression	NULL
vectors	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
COS-7	NULL
nuclear	NULL
cell	NULL
extract	NULL
and	NULL
40	NULL
fmol	NULL
of	NULL
a	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
JATP	NULL
end-labeled	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
one	NULL
Gal4-binding	NULL
site	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
and	NULL
free	NULL
probe	NULL
were	NULL
separated	NULL
by	NULL
electrophore-sis	NULL
through	NULL
a	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
80:1	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
free	NULL
probe	NULL
;	NULL
lanes	NULL
2-8	NULL
,	NULL
expressed	NULL
GALA	NULL
fusion	NULL
protein	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
extract	NULL
of	NULL
mock-transfected	NULL
cells	NULL
.	NULL

Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-Nuclear	NULL
extracts	NULL
from	NULL
transfected	NULL
COS-7	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
small	NULL
scale	NULL
procedure	NULL
(	NULL
27	NULL
)	NULL
.	NULL

EMSA	NULL
reactions	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
were	NULL
set	NULL
up	NULL
in	NULL
20	NULL
ul	NULL
with	NULL
2.5	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
40	NULL
fmol	NULL
of	NULL
an	NULL
end-labeled	NULL
probe	NULL
containing	NULL
a	NULL
single	NULL
Gal4-binding	NULL
site	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
denatured	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
MgC	NULL
]	NULL
,	NULL
,	NULL
10	NULL
pm	NULL
ZnCl	NULL
,	NULL
,	NULL
6	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
200	NULL
ug/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
resolved	NULL
at	NULL
15	NULL
V/em	NULL
for	NULL
2	NULL
h	NULL
on	NULL
a	NULL
native	NULL
pre-run	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
80:1	NULL
)	NULL
containing	NULL
0.5	NULL
x	NULL
TBE	NULL
and	NULL
1	NULL
%	NULL
glycerol	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
fixed	NULL
for	NULL
30	NULL
min	NULL
in	NULL
20	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
methanol	NULL
and	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
acetic	NULL
acid	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
.	NULL

Luciferase	NULL
Assays-Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
using	NULL
a	NULL
Berthold	NULL
MicroLumat	NULL
LB96P	NULL
machine	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thaw	NULL
lysis	NULL
in	NULL
0.1	NULL
M	NULL
potassium	NULL
phosphate	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
dithiothre-itol	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
200	NULL
Ll	NULL
containing	NULL
100	NULL
ug	NULL
of	NULL
the	NULL
protein	NULL
extract	NULL
,	NULL
11.25	NULL
mm	NULL
MgSQO	NULL
,	NULL
,	NULL
18.75	NULL
mm	NULL
glycine	NULL
,	NULL
2.0	NULL
mm	NULL
ATP	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
and	NULL
0.15	NULL
mM	NULL
of	NULL
the	NULL
substrate	NULL
b-luciferin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
pH	NULL
7.8	NULL
.	NULL

Light	NULL
output	NULL
was	NULL
measured	NULL
for	NULL
15	NULL
s.	NULL
RESULTS	NULL
AND	NULL
DISCUSSION	NULL
In	NULL
our	NULL
previous	NULL
experiments	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
Oct-2a	NULL
is	NULL
a	NULL
complex	NULL
transcription	NULL
factor	NULL
consisting	NULL
of	NULL
separable	NULL
modules	NULL
for	NULL
activation	NULL
and	NULL
repression	NULL
.	NULL

The	NULL
repression	NULL
domain	NULL
was	NULL
localized	NULL
to	NULL
the	NULL
N-terminal	NULL
99	NULL
amino	NULL
acids	NULL
of	NULL
Oct-2a	NULL
,	NULL
the	NULL
N1	NULL
region	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
further	NULL
delineate	NULL
the	NULL
domain	NULL
important	NULL
for	NULL
repression	NULL
,	NULL
we	NULL
have	NULL
performed	NULL
a	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
N1	NULL
region	NULL
.	NULL

Various	NULL
expression	NULL
vectors	NULL
were	NULL
generated	NULL
containing	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
N1	NULL
segment	NULL
,	NULL
comprising	NULL
the	NULL
repression	NULL
domain	NULL
,	NULL
fused	NULL
to	NULL
a	NULL
potent	NULL
activator	NULL
protein	NULL
.	NULL

The	NULL
regions	NULL
N1	NULL
(	NULL
amino	NULL
acids	NULL
2-99	NULL
)	NULL
,	NULL
N2	NULL
(	NULL
amino	NULL
acids	NULL
163-207	NULL
)	NULL
,	NULL
N3	NULL
(	NULL
amino	NULL
acids	NULL
2-64	NULL
)	NULL
,	NULL
N4	NULL
(	NULL
residues	NULL
42-99	NULL
)	NULL
,	NULL
and	NULL
NS	NULL
(	NULL
residues	NULL
65-99	NULL
)	NULL
of	NULL
Oct-2a	NULL
were	NULL
linked	NULL
to	NULL
GALA-C-C	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

As	NULL
judged	NULL
by	NULL
EMSA	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
transfected	NULL
COS-7	NULL
cells	NULL
,	NULL
all	NULL
of	NULL
these	NULL
fusion	NULL
proteins	NULL
were	NULL
expressed	NULL
at	NULL
comparable	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
were	NULL
performed	NULL
in	NULL
Hela	NULL
and	NULL
Nama-Iwa	NULL
cells	NULL
with	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
p2GlucE	NULL
and	NULL
p2GlucBGS	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
vectors	NULL
differ	NULL
with	NULL
respect	NULL
to	NULL
their	NULL
enhancers	NULL
;	NULL
p2GlucE	NULL
contains	NULL
an	NULL
SV40	NULL
enhancer	NULL
,	NULL
and	NULL
p2GlucBGS	NULL
contains	NULL
a	NULL
synthetic	NULL
enhancer	NULL
consisting	NULL
of	NULL
five	NULL
Gal4-binding	NULL
sites	NULL
(	NULL
see	NULL
also	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

In	NULL
Namalwa	NULL
cells	NULL
,	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
cotrans-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Repression	NULL
by	NULL
Oct-2A	NULL
15	NULL
W	NULL
Hola	NULL
C	NULL
Namalwa	NULL
12	NULL
>	NULL
#	NULL
&	NULL
”	NULL
g	NULL
9	NULL
$	NULL
3	NULL
%	NULL
S	NULL
o	NULL
2	NULL
3	NULL
0	NULL
B	NULL
t	NULL
th	NULL
t	NULL
CA	NULL
,	NULL
%	NULL
,	NULL
%	NULL
x	NULL
x	NULL
,	NULL
``	NULL
o	NULL
Q2	NULL
,	NULL
Q7	NULL
<	NULL
7	NULL
Q2	NULL
,	NULL
07g	NULL
,	NULL
Q2	NULL
,	NULL
;	NULL
,	NULL
.	NULL

;	NULL
;	NULL
,	NULL
'	NULL
o	NULL
0	NULL
Q0	NULL
Q0	NULL
Q0	NULL
0	NULL
peGlucE	NULL
TATA	NULL
g	NULL
luciferase	NULL
$	NULL
V40	NULL
enhancer	NULL
2x	NULL
Gal	NULL
280	NULL
E	NULL
Hela	NULL
240	NULL
-	NULL
U	NULL
Namalwa	NULL
g	NULL
200	NULL
4	NULL
2	NULL
r	NULL
&	NULL
160	NULL
o	NULL
a	NULL
1204	NULL
<	NULL
2	NULL
-	NULL
so	NULL
404	NULL
p2GIucBGS	NULL
TATA	NULL
z	NULL
luciferase	NULL
2x	NULL
Gald	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
transcriptional	NULL
repression	NULL
domain	NULL
within	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
Oct-2a	NULL
.	NULL

A	NULL
,	NULL
Helia	NULL
and	NULL
Namalwa	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
6	NULL
ug	NULL
of	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
p2GlucE	NULL
and	NULL
4	NULL
ug	NULL
of	NULL
various	NULL
expression	NULL
vectors	NULL
containing	NULL
potential	NULL
repression	NULL
domains	NULL
linked	NULL
to	NULL
the	NULL
potent	NULL
activator	NULL
GAL4-C-C.	NULL
B	NULL
,	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
p2GlucBGS	NULL
was	NULL
used	NULL
for	NULL
cotransfections	NULL
into	NULL
HeLa	NULL
and	NULL
Nama-Iwa	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
expression	NULL
vectors	NULL
used	NULL
in	NULL
A	NULL
.	NULL

For	NULL
A	NULL
and	NULL
B	NULL
,	NULL
transfections	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
GAL4	NULL
(	NULL
aa	NULL
1-147	NULL
)	NULL
on	NULL
the	NULL
target	NULL
vectors	NULL
p2GucE	NULL
and	NULL
p2GlucBGS	NULL
was	NULL
arbitrarily	NULL
set	NULL
to	NULL
1	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

The	NULL
activation	NULL
potential	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
expressed	NULL
relative	NULL
to	NULL
GAL4	NULL
(	NULL
aa	NULL
1-147	NULL
)	NULL
.	NULL

Standard	NULL
deviations	NULL
of	NULL
at	NULL
least	NULL
five	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
as	NULL
error	NULL
bars	NULL
.	NULL

fection	NULL
of	NULL
the	NULL
expression	NULL
vectors	NULL
together	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
p2GlucE	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
led	NULL
to	NULL
transcriptional	NULL
repression	NULL
with	NULL
the	NULL
constructs	NULL
N1-GAL4-C-C	NULL
,	NULL
N3-GAL4-C-C	NULL
,	NULL
and	NULL
N4-GAL4-C-C	NULL
,	NULL
but	NULL
no	NULL
repression	NULL
was	NULL
seen	NULL
either	NULL
with	NULL
N5-GAL4-C-C	NULL
or	NULL
with	NULL
the	NULL
control	NULL
N2-GAL4-C-C	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
repression	NULL
is	NULL
dependent	NULL
on	NULL
residues	NULL
common	NULL
to	NULL
N1	NULL
,	NULL
N3	NULL
,	NULL
and	NULL
N4	NULL
,	NULL
which	NULL
comprise	NULL
a	NULL
region	NULL
at	NULL
amino	NULL
acids	NULL
42-64	NULL
of	NULL
Oct-2a	NULL
.	NULL

The	NULL
localization	NULL
of	NULL
the	NULL
repression	NULL
domain	NULL
to	NULL
this	NULL
short	NULL
region	NULL
of	NULL
23	NULL
amino	NULL
acids	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
N4	NULL
shows	NULL
the	NULL
same	NULL
degree	NULL
of	NULL
repression	NULL
as	NULL
the	NULL
N1	NULL
region	NULL
,	NULL
containing	NULL
the	NULL
complete	NULL
repression	NULL
domain	NULL
,	NULL
whereas	NULL
region	NULL
N5	NULL
does	NULL
not	NULL
show	NULL
any	NULL
inhibitory	NULL
activity	NULL
.	NULL

None	NULL
of	NULL
the	NULL
constructs	NULL
tested	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
an	NULL
epitheloid	NULL
cancer	NULL
cell	NULL
line	NULL
,	NULL
could	NULL
repress	NULL
transcription	NULL
,	NULL
and	NULL
all	NULL
displayed	NULL
the	NULL
same	NULL
activity	NULL
as	NULL
GAL4-C-C	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
previous	NULL
results	NULL
(	NULL
12	NULL
)	NULL
and	NULL
shows	NULL
that	NULL
repression	NULL
is	NULL
impaired	NULL
by	NULL
a	NULL
Hela	NULL
cell-specific	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

3B	NULL
the	NULL
same	NULL
series	NULL
of	NULL
expression	NULL
vectors	NULL
was	NULL
tested	NULL
together	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
p2GlucBG5	NULL
.	NULL

Repression	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
constructs	NULL
N1-GAL4-C-C	NULL
,	NULL
N3-GAL4-	NULL
13929	NULL
activation	NULL
domain	NULL
I	NULL
OctzA	NULL
1	NULL
[	NULL
L7	NULL
Repression	NULL
seee	NULL
+++	NULL
++++	NULL
|_|	NULL
42	NULL
HQNPQNKTSPFSVSPTGPSTKIK	NULL
64	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Schematic	NULL
outline	NULL
of	NULL
the	NULL
minimal	NULL
repression	NULL
domain	NULL
of	NULL
Oct-2a	NULL
.	NULL

The	NULL
inhibitory	NULL
activity	NULL
was	NULL
assigned	NULL
to	NULL
a	NULL
23-amino	NULL
acid	NULL
stretch	NULL
(	NULL
dark	NULL
box	NULL
)	NULL
within	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
Oct-2a	NULL
.	NULL

This	NULL
region	NULL
is	NULL
rich	NULL
in	NULL
serine	NULL
and	NULL
threonine	NULL
residues	NULL
and	NULL
does	NULL
not	NULL
show	NULL
homology	NULL
to	NULL
other	NULL
transcriptional	NULL
repressor	NULL
proteins	NULL
.	NULL

C-C	NULL
,	NULL
and	NULL
N4-GALA4-C-C	NULL
,	NULL
and	NULL
no	NULL
repression	NULL
was	NULL
seen	NULL
with	NULL
N5-GAL4-C-C	NULL
and	NULL
the	NULL
control	NULL
N2-GAL4-C-C	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
.	NULL

Interestingly	NULL
,	NULL
transcriptional	NULL
repression	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
p2GlucBGS	NULL
was	NULL
observed	NULL
in	NULL
all	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

Again	NULL
N4-GAL4-C-C	NULL
repressed	NULL
transcription	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
N1-GAL4-C-C	NULL
,	NULL
whereas	NULL
N5-GAL4-C-C	NULL
did	NULL
not	NULL
inhibit	NULL
transcription	NULL
in	NULL
Hela	NULL
cells	NULL
and	NULL
had	NULL
only	NULL
a	NULL
minor	NULL
effect	NULL
in	NULL
Namalwa	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
repression	NULL
domain	NULL
of	NULL
Oct-2a	NULL
can	NULL
be	NULL
mapped	NULL
to	NULL
residues	NULL
42-64	NULL
.	NULL

The	NULL
relative	NULL
position	NULL
of	NULL
the	NULL
various	NULL
domains	NULL
tested	NULL
(	NULL
N1	NULL
,	NULL
N2	NULL
,	NULL
N3	NULL
,	NULL
N4	NULL
,	NULL
and	NULL
N5	NULL
)	NULL
within	NULL
the	NULL
Oct-2a	NULL
N	NULL
terminus	NULL
and	NULL
the	NULL
minimal	NULL
repression	NULL
domain	NULL
(	NULL
dark	NULL
box	NULL
)	NULL
are	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

As	NULL
mentioned	NULL
above	NULL
,	NULL
region	NULL
N4	NULL
represses	NULL
transcription	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
the	NULL
extended	NULL
N1	NULL
region	NULL
.	NULL

However	NULL
,	NULL
the	NULL
N3	NULL
domain	NULL
is	NULL
slightly	NULL
less	NULL
efficient	NULL
than	NULL
N4	NULL
in	NULL
inhibiting	NULL
transcription	NULL
despite	NULL
containing	NULL
the	NULL
minimal	NULL
repression	NULL
domain	NULL
.	NULL

This	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
slight	NULL
destabilization	NULL
of	NULL
the	NULL
protein	NULL
structure	NULL
of	NULL
the	NULL
N3	NULL
domain	NULL
,	NULL
since	NULL
a	NULL
high	NULL
probability	NULL
for	NULL
a	NULL
B	NULL
sheet	NULL
was	NULL
predicted	NULL
for	NULL
exactly	NULL
the	NULL
C-terminal	NULL
end	NULL
of	NULL
N3	NULL
(	NULL
program	NULL
Pre-dictProtein	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
inhibitory	NULL
domain	NULL
.	NULL

This	NULL
region	NULL
could	NULL
be	NULL
stabilized	NULL
by	NULL
the	NULL
additional	NULL
C-terminal	NULL
residues	NULL
present	NULL
in	NULL
the	NULL
N4	NULL
domain	NULL
.	NULL

These	NULL
residues	NULL
could	NULL
favor	NULL
the	NULL
correct	NULL
folding	NULL
of	NULL
the	NULL
inhibitory	NULL
domain	NULL
giving	NULL
rise	NULL
to	NULL
maximal	NULL
transcriptional	NULL
repression	NULL
.	NULL

Repression	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
p2GlucBGS5	NULL
by	NULL
N4-GAL4C-C	NULL
was	NULL
observed	NULL
in	NULL
both	NULL
Hela	NULL
and	NULL
Namalwa	NULL
cells	NULL
.	NULL

In	NULL
con-trast	NULL
,	NULL
repression	NULL
of	NULL
the	NULL
target	NULL
vector	NULL
p2GlucE	NULL
was	NULL
only	NULL
seen	NULL
in	NULL
Namalwa	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
data	NULL
(	NULL
12	NULL
)	NULL
and	NULL
underlines	NULL
that	NULL
repression	NULL
by	NULL
Oct-2a	NULL
follows	NULL
cell	NULL
type-specific	NULL
characteristics	NULL
that	NULL
are	NULL
strongly	NULL
determined	NULL
by	NULL
the	NULL
enhancer	NULL
present	NULL
on	NULL
the	NULL
reporter	NULL
plasmid	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
repression	NULL
by	NULL
N4-GAL4-C-C	NULL
is	NULL
impaired	NULL
by	NULL
a	NULL
Hela	NULL
cell-specific	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
interacting	NULL
with	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

Such	NULL
a	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
could	NULL
interfere	NULL
with	NULL
repression	NULL
by	NULL
masking	NULL
the	NULL
inhibitory	NULL
domain	NULL
of	NULL
Oct-2a	NULL
.	NULL

This	NULL
working	NULL
model	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
Oct-2a	NULL
can	NULL
exert	NULL
its	NULL
negative	NULL
effect	NULL
when	NULL
linked	NULL
to	NULL
other	NULL
Oct-2a	NULL
activation	NULL
domains	NULL
only	NULL
if	NULL
Hela	NULL
cell-specific	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
SV40	NULL
enhancer	NULL
are	NULL
not	NULL
present	NULL
(	NULL
Namalwa	NULL
cells	NULL
)	NULL
or	NULL
are	NULL
not	NULL
able	NULL
to	NULL
bind	NULL
(	NULL
synthetic	NULL
Gal4	NULL
enhancer	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Region	NULL
N4	NULL
,	NULL
containing	NULL
the	NULL
minimal	NULL
repression	NULL
domain	NULL
between	NULL
residues	NULL
42-64	NULL
,	NULL
is	NULL
a	NULL
transferable	NULL
inhibitory	NULL
domain	NULL
that	NULL
works	NULL
independently	NULL
of	NULL
its	NULL
cognate	NULL
DNA-binding	NULL
POU	NULL
domain	NULL
.	NULL

N4	NULL
linked	NULL
to	NULL
the	NULL
activator	NULL
GAL4-C-C	NULL
efficiently	NULL
inhibits	NULL
transcription	NULL
and	NULL
can	NULL
therefore	NULL
be	NULL
classified	NULL
as	NULL
an	NULL
active	NULL
transcriptional	NULL
repressor	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
32	NULL
)	NULL
.	NULL

This	NULL
class	NULL
of	NULL
repression	NULL
domains	NULL
is	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
13930	NULL
implicated	NULL
in	NULL
contacting	NULL
components	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
apparatus	NULL
,	NULL
thus	NULL
interfering	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
transcrip-tion-competent	NULL
initiation	NULL
complex	NULL
.	NULL

This	NULL
was	NULL
recently	NULL
demonstrated	NULL
for	NULL
Dr1	NULL
(	NULL
83	NULL
)	NULL
and	NULL
the	NULL
Drosophila	NULL
proteins	NULL
Kriippel	NULL
(	NULL
34	NULL
)	NULL
and	NULL
Even-skipped	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
the	NULL
native	NULL
Oct-2a	NULL
protein	NULL
,	NULL
repression	NULL
could	NULL
follow	NULL
a	NULL
combination	NULL
of	NULL
different	NULL
mechanisms	NULL
including	NULL
competition	NULL
for	NULL
DNA-binding	NULL
sites	NULL
and	NULL
quenching	NULL
,	NULL
both	NULL
requiring	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
homologous	NULL
DNA-binding	NULL
POU	NULL
domain	NULL
,	NULL
or	NULL
interaction	NULL
with	NULL
basal	NULL
transcription	NULL
factors	NULL
.	NULL

This	NULL
is	NULL
not	NULL
unexpected	NULL
since	NULL
different	NULL
mechanisms	NULL
of	NULL
repression	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
promoter	NULL
architecture	NULL
and	NULL
the	NULL
type	NULL
and	NULL
amount	NULL
of	NULL
distinct	NULL
factors	NULL
present	NULL
in	NULL
the	NULL
cellular	NULL
context	NULL
,	NULL
are	NULL
used	NULL
by	NULL
repressor	NULL
proteins	NULL
such	NULL
as	NULL
Kriippel	NULL
(	NULL
22	NULL
,	NULL
34	NULL
,	NULL
36	NULL
)	NULL
and	NULL
Even-skipped	NULL
(	NULL
35	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
repression	NULL
domain	NULL
of	NULL
Oct-2a	NULL
,	NULL
which	NULL
mapped	NULL
to	NULL
amino	NULL
acids	NULL
42-64	NULL
,	NULL
is	NULL
rich	NULL
in	NULL
serine	NULL
and	NULL
threonine	NULL
residues	NULL
(	NULL
30.4	NULL
%	NULL
)	NULL
.	NULL

Protein	NULL
data	NULL
base	NULL
searches	NULL
with	NULL
this	NULL
region	NULL
did	NULL
not	NULL
reveal	NULL
a	NULL
significant	NULL
homology	NULL
to	NULL
other	NULL
known	NULL
transcriptional	NULL
repres-sors	NULL
,	NULL
and	NULL
no	NULL
particular	NULL
structural	NULL
motifs	NULL
were	NULL
found	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
region	NULL
could	NULL
represent	NULL
a	NULL
novel	NULL
type	NULL
of	NULL
repression	NULL
domain	NULL
.	NULL

Experiments	NULL
to	NULL
identify	NULL
possible	NULL
targets	NULL
of	NULL
the	NULL
Oct-2a	NULL
inhibitory	NULL
domain	NULL
using	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
are	NULL
currently	NULL
in	NULL
progress	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

Recently	NULL
,	NULL
negative	NULL
regulatory	NULL
domains	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
within	NULL
other	NULL
isoforms	NULL
of	NULL
Oct-2	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

These	NULL
domains	NULL
are	NULL
neither	NULL
related	NULL
to	NULL
each	NULL
other	NULL
nor	NULL
to	NULL
the	NULL
repression	NULL
domain	NULL
mapped	NULL
in	NULL
this	NULL
study	NULL
.	NULL

One	NULL
of	NULL
these	NULL
regions	NULL
was	NULL
assigned	NULL
to	NULL
an	NULL
N-terminal	NULL
domain	NULL
common	NULL
to	NULL
both	NULL
the	NULL
neuronally	NULL
expressed	NULL
mouse	NULL
isoforms	NULL
Oct	NULL
2.4	NULL
and	NULL
Oct	NULL
2.5	NULL
(	NULL
13	NULL
)	NULL
.	NULL

This	NULL
region	NULL
specifically	NULL
inhibited	NULL
activation	NULL
of	NULL
a	NULL
herpes	NULL
simplex	NULL
virus	NULL
immediate-early	NULL
promoter	NULL
containing	NULL
the	NULL
octamer/TAATGARAT	NULL
motif	NULL
and	NULL
was	NULL
implicated	NULL
in	NULL
the	NULL
production	NULL
of	NULL
latent	NULL
infection	NULL
in	NULL
neuronal	NULL
cells	NULL
upon	NULL
exposure	NULL
to	NULL
herpes	NULL
simplex	NULL
virus	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
other	NULL
repression	NULL
domain	NULL
identified	NULL
was	NULL
localized	NULL
to	NULL
a	NULL
region	NULL
that	NULL
is	NULL
unique	NULL
to	NULL
the	NULL
mouse	NULL
isoform	NULL
Oct	NULL
2.3	NULL
(	NULL
14	NULL
)	NULL
,	NULL
but	NULL
is	NULL
not	NULL
present	NULL
in	NULL
any	NULL
of	NULL
the	NULL
other	NULL
Oct-2	NULL
isoforms	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
non-related	NULL
repression	NULL
domains	NULL
within	NULL
splice	NULL
variants	NULL
of	NULL
Oct-2	NULL
indicates	NULL
that	NULL
transcriptional	NULL
repression	NULL
by	NULL
the	NULL
various	NULL
Oct-2	NULL
isoforms	NULL
might	NULL
follow	NULL
distinct	NULL
regulatory	NULL
mechanisms	NULL
,	NULL
which	NULL
could	NULL
be	NULL
dependent	NULL
on	NULL
the	NULL
cellular	NULL
context	NULL
and	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
target	NULL
promoter	NULL
.	NULL

The	NULL
complex	NULL
modular	NULL
structure	NULL
of	NULL
Oct-2a	NULL
,	NULL
which	NULL
includes	NULL
distinct	NULL
domains	NULL
for	NULL
activation	NULL
and	NULL
repression	NULL
,	NULL
could	NULL
have	NULL
important	NULL
implications	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
B	NULL
cell-specific	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
B	NULL
cell	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
Oct-2-regulated	NULL
target	NULL
genes	NULL
.	NULL

The	NULL
promoters	NULL
of	NULL
several	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
Ig	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
genes	NULL
,	NULL
and	NULL
of	NULL
genes	NULL
coding	NULL
for	NULL
B29	NULL
(	NULL
Ig	NULL
)	NULL
,	NULL
CD21	NULL
(	NULL
Cr2	NULL
)	NULL
,	NULL
and	NULL
CD20	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
octamer	NULL
site-dependent	NULL
and	NULL
B	NULL
cell-specific	NULL
,	NULL
but	NULL
not	NULL
strictly	NULL
dependent	NULL
on	NULL
Oct-2	NULL
expression	NULL
(	NULL
8	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
murine	NULL
CD36	NULL
gene	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
critically	NULL
dependent	NULL
on	NULL
Oct-2	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
macrophages	NULL
so	NULL
far	NULL
,	NULL
although	NULL
the	NULL
precise	NULL
function	NULL
of	NULL
this	NULL
gene	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
role	NULL
in	NULL
the	NULL
terminal	NULL
phase	NULL
of	NULL
B	NULL
cell	NULL
devel-opment	NULL
,	NULL
Oct-2	NULL
may	NULL
also	NULL
be	NULL
critical	NULL
for	NULL
developmental	NULL
processes	NULL
outside	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
because	NULL
Oct-2-deficient	NULL
mice	NULL
die	NULL
within	NULL
hours	NULL
of	NULL
birth	NULL
(	NULL
7	NULL
)	NULL
.	NULL

This	NULL
strongly	NULL
indicates	NULL
that	NULL
developmentally	NULL
relevant	NULL
genes	NULL
exist	NULL
,	NULL
whose	NULL
activation	NULL
or	NULL
repression	NULL
may	NULL
be	NULL
required	NULL
for	NULL
the	NULL
postnatal	NULL
survival	NULL
of	NULL
the	NULL
newborn	NULL
mouse	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Since	NULL
Oct-2	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
the	NULL
developing	NULL
Repression	NULL
by	NULL
Oct-2A	NULL
nervous	NULL
system	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
adult	NULL
brain	NULL
of	NULL
mice	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
activation	NULL
and	NULL
repression	NULL
by	NULL
Oct-2	NULL
may	NULL
have	NULL
an	NULL
impact	NULL
on	NULL
the	NULL
fine-tuning	NULL
of	NULL
gene	NULL
regulation	NULL
in	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
Oct-2a	NULL
target	NULL
genes	NULL
will	NULL
contribute	NULL
significantly	NULL
to	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
complex	NULL
regulatory	NULL
functions	NULL
of	NULL
Oct-2a	NULL
and	NULL
its	NULL
biological	NULL
role	NULL
in	NULL
B	NULL
cell	NULL
differentiation	NULL
and	NULL
general	NULL
development	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Edward	NULL
J.	NULL
Oakeley	NULL
and	NULL
Jan	NULL
E.	NULL
Reichert	NULL
for	NULL
critical	NULL
review	NULL
and	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9	NULL
,	NULL
373-398	NULL
2	NULL
.	NULL

Wegner	NULL
,	NULL
M.	NULL
,	NULL
Drolet	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5	NULL
,	NULL
488-498	NULL
3	NULL
.	NULL

Sturm	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Das	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1582-1599	NULL
4	NULL
.	NULL

Miller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
836	NULL
,	NULL
544-551	NULL
5	NULL
.	NULL

Scholer	NULL
,	NULL
H.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

7	NULL
,	NULL
323-329	NULL
6	NULL
.	NULL

Verrijzer	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
and	NULL
Van	NULL
der	NULL
Vliet	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1178	NULL
,	NULL
1-21	NULL
7	NULL
.	NULL

Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Karvelas	NULL
,	NULL
M.	NULL
,	NULL
Nossal	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Ye	NULL
,	NULL
Z.	NULL
S.	NULL
,	NULL
Jacks	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
570-582	NULL
8	NULL
.	NULL

Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Karvelas	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
635-645	NULL
9	NULL
.	NULL

Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
Knoepfel	NULL
,	NULL
L.	NULL
,	NULL
Georgiev	NULL
,	NULL
O.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Hovens	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
873	NULL
,	NULL
360-362	NULL
10	NULL
.	NULL

Strubin	NULL
,	NULL
M.	NULL
,	NULL
Newell	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
497-506	NULL
11	NULL
.	NULL

Luo	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
4115-4124	NULL
12	NULL
.	NULL

Friedl	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

284	NULL
,	NULL
308-316	NULL
13	NULL
.	NULL

Lillycrop	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Dawson	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Estridge	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Gerster	NULL
,	NULL
T.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Latchman	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
7633-7642	NULL
14	NULL
.	NULL

Annweiler	NULL
,	NULL
A.	NULL
,	NULL
Zwilling	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
4250-4258	NULL
15	NULL
.	NULL

Goodrich	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6	NULL
,	NULL
403-409	NULL
16	NULL
.	NULL

Tjian	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
5-8	NULL
17	NULL
.	NULL

Guarente	NULL
,	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
,	NULL
517-521	NULL
18	NULL
.	NULL

Herschbach	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

9	NULL
,	NULL
479-509	NULL
19	NULL
.	NULL

Cowell	NULL
,	NULL
I.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19	NULL
,	NULL
38-42	NULL
20	NULL
.	NULL

Johnson	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
81	NULL
,	NULL
655-658	NULL
21	NULL
.	NULL

Roberts	NULL
,	NULL
S.	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
875	NULL
,	NULL
105-106	NULL
22	NULL
.	NULL

Licht	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Hanna-Rose	NULL
,	NULL
W.	NULL
,	NULL
Reddy	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
English	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Ro	NULL
,	NULL
M.	NULL
,	NULL
Grossel	NULL
,	NULL
M.	NULL
,	NULL
Shaknovich	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Hansen	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4057-4066	NULL
23	NULL
.	NULL

Gashler	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Swaminathan	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
4556-4571	NULL
24	NULL
.	NULL

Shi	NULL
,	NULL
Y.	NULL
,	NULL
Seto	NULL
,	NULL
E.	NULL
,	NULL
Chang	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
and	NULL
Shenk	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
377-388	NULL
25	NULL
.	NULL

Wigler	NULL
,	NULL
M.	NULL
,	NULL
Pellicer	NULL
,	NULL
A.	NULL
,	NULL
Silverstein	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Axel	NULL
,	NULL
R.	NULL
(	NULL
1978	NULL
)	NULL
Cell	NULL
14	NULL
,	NULL
725-731	NULL
26	NULL
.	NULL

Junker	NULL
,	NULL
S.	NULL
,	NULL
Nielsen	NULL
,	NULL
V.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Picard	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
3093-3098	NULL
27	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
28	NULL
.	NULL

Carey	NULL
,	NULL
M.	NULL
,	NULL
Kakidani	NULL
,	NULL
H.	NULL
,	NULL
Leatherwood	NULL
,	NULL
J.	NULL
,	NULL
Mostashari	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

209	NULL
,	NULL
423-432	NULL
29	NULL
.	NULL

Gerber	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Seipel	NULL
,	NULL
K.	NULL
,	NULL
Georgiev	NULL
,	NULL
O.	NULL
,	NULL
Hofferer	NULL
,	NULL
M.	NULL
,	NULL
Hug	NULL
,	NULL
M.	NULL
,	NULL
Rusconi	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
808-811	NULL
30	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Struhl	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
Vol	NULL
.	NULL

1	NULL
,	NULL
pp	NULL
.	NULL

9.6.10-9.6.14	NULL
,	NULL
John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
31.	NULL
de	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Wood	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
Deluca	NULL
,	NULL
M.	NULL
,	NULL
Helinski	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Subramani	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
725-737	NULL
32	NULL
.	NULL

Levine	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Manley	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
405-408	NULL
33	NULL
.	NULL

Yeung	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Inostroza	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Mermelstein	NULL
,	NULL
F.	NULL
H.	NULL
,	NULL
Kannabrian	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Reinberg	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

11	NULL
,	NULL
173-178	NULL
34	NULL
.	NULL

Sauer	NULL
,	NULL
F.	NULL
,	NULL
Fondell	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Ohkuma	NULL
,	NULL
Y.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Jickle	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
375	NULL
,	NULL
162-164	NULL
35	NULL
.	NULL

Um	NULL
,	NULL
M.	NULL
,	NULL
Li	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Manley	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
5007-5016	NULL
36	NULL
.	NULL

Licht	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Ro	NULL
,	NULL
M.	NULL
,	NULL
English	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Grossel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hansen	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11361-11365	NULL
37	NULL
.	NULL

Austin	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Biggin	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
4683-4698	NULL
38	NULL
.	NULL

Wirth	NULL
,	NULL
T.	NULL
,	NULL
Priess	NULL
,	NULL
A.	NULL
,	NULL
Annweiler	NULL
,	NULL
A.	NULL
,	NULL
Zwilling	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Oeler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
48-51	NULL
39	NULL
.	NULL

Feldhaus	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Klug	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Arvin	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Singh	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2763-2772	NULL
40	NULL
.	NULL

Kénig	NULL
,	NULL
H.	NULL
,	NULL
Pfisterer	NULL
,	NULL
P.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
1598-1607	NULL
41	NULL
.	NULL

Hatzopoulos	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Stoykova	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Erselius	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Goulding	NULL
,	NULL
M.	NULL
,	NULL
Neuman	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Development	NULL
109	NULL
,	NULL
349-362	NULL
42	NULL
.	NULL

Stoykova	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Sterrer	NULL
,	NULL
S.	NULL
,	NULL
Erselius	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Hatzopoulos	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
and	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Neuron	NULL
8	NULL
,	NULL
541-558	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Mapping	NULL
of	NULL
the	NULL
Transcriptional	NULL
Repression	NULL
Domain	NULL
of	NULL
the	NULL
Lymphoid-specific	NULL
Transcription	NULL
Factor	NULL
Oct-2A	NULL
Erika	NULL
M.	NULL
Friedl	NULL
and	NULL
Patrick	NULL
Matthias	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:13927-13930.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.24.13927	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/24/1	NULL
3927	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
42	NULL
references	NULL
,	NULL
13	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
3927	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

